Cite
Humoral Immune Response of Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Prime-Boost Vaccination against SARS-CoV-2 Variants in Korea.
MLA
Heeji Lim, et al. “Humoral Immune Response of Heterologous ChAdOx1 NCoV-19 and MRNA-1273 Prime-Boost Vaccination against SARS-CoV-2 Variants in Korea.” Infection & Chemotherapy, vol. 55, no. 1, Mar. 2023, pp. 99–104. EBSCOhost, https://doi.org/10.3947/ic.2022.0132.
APA
Heeji Lim, Sundong Jang, Hyun Ju In, Kwangwook Kim, Eun Bee Choi, Soo Ji Kim, Hye Jung Lim, Min Su Yim, In-ohk Ouh, Byung Chul Kim, Hyeon Nam Do, June-Woo Lee, Byoungguk Kim, & Yoo-kyoung Lee. (2023). Humoral Immune Response of Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Prime-Boost Vaccination against SARS-CoV-2 Variants in Korea. Infection & Chemotherapy, 55(1), 99–104. https://doi.org/10.3947/ic.2022.0132
Chicago
Heeji Lim, Sundong Jang, Hyun Ju In, Kwangwook Kim, Eun Bee Choi, Soo Ji Kim, Hye Jung Lim, et al. 2023. “Humoral Immune Response of Heterologous ChAdOx1 NCoV-19 and MRNA-1273 Prime-Boost Vaccination against SARS-CoV-2 Variants in Korea.” Infection & Chemotherapy 55 (1): 99–104. doi:10.3947/ic.2022.0132.